Boussard & Gavaudan Holding Ltd (GBP): Circular
Please find attached the circularAttachment1. BGHL – AGM Circular final version v5 -Final version
Day: August 27, 2021
Boussard & Gavaudan Holding Ltd (GBP): Notice of AGM
Written by Customer Service on . Posted in Public Companies.
BOUSSARD & GAVAUDAN HOLDING LIMITEDRegistration Number: 45582
Registered Office: Ground Floor, Dorey Court, Admiral Park, St Peter Port, Guernsey, GY1 2HTTel: +44 (0)1481 702 400 Fax: +44 (0)1481 702 407
NOTICE OF ANNUAL GENERAL MEETING
NOTICE IS HEREBY GIVEN that the Annual General Meeting (the “AGM”) of the Company will be held at Ground Floor, Dorey Court, Admiral Park, St. Peter Port, Guernsey on Thursday, 23 September 2021 at 10:00 a.m. for the purpose of considering and, if thought fit, passing the following resolutions:Ordinary Business – Ordinary Resolutions1.
THAT the Company’s annual report and audited financial statements for the year ended 31 December 2020 be received and adopted.2.
THAT Ernst & Young LLP be re-appointed as auditor of the Company, to hold such office until the conclusion of the next...
Good Works Acquisition Corp. and Cipher Mining Announce Closing of Business Combination; Cipher Mining to Trade on Nasdaq Under Ticker Symbols “CIFR” and “CIFRW”
Written by Customer Service on . Posted in Mergers And Acquisitions.
NEW YORK, Aug. 27, 2021 (GLOBE NEWSWIRE) — Cipher Mining Technologies Inc., a U.S.-based Bitcoin mining company, today announced that it completed its business combination with Good Works Acquisition Corp. (“Good Works”) (NASDAQ: GWAC), a U.S. publicly-traded special purpose acquisition company. Good Works shareholders approved the business combination at a special meeting held on August 25, 2021.
Following the merger, the combined company is named Cipher Mining Inc. (“Cipher Mining”). Beginning on Monday, August 30, 2021, Cipher Mining’s ordinary shares and warrants will trade on Nasdaq under the ticker symbols “CIFR” and “CIFRW”, respectively.
Cipher Mining’s experienced management team will be led by Chief Executive Officer Tyler Page. The Board of Directors of Cipher Mining (the “Board”) is composed of James “Jim” Newsome (Chair),...
Boussard & Gavaudan Holding Ltd (EUR): Circular
Written by Customer Service on . Posted in Public Companies.
Please find attached the circularAttachment1. BGHL – AGM Circular final version v5 -Final version
Boussard & Gavaudan Holding Ltd (EUR): Notice of AGM
Written by Customer Service on . Posted in Public Companies.
BOUSSARD & GAVAUDAN HOLDING LIMITEDRegistration Number: 45582
Registered Office: Ground Floor, Dorey Court, Admiral Park, St Peter Port, Guernsey, GY1 2HTTel: +44 (0)1481 702 400 Fax: +44 (0)1481 702 407
NOTICE OF ANNUAL GENERAL MEETING
NOTICE IS HEREBY GIVEN that the Annual General Meeting (the “AGM”) of the Company will be held at Ground Floor, Dorey Court, Admiral Park, St. Peter Port, Guernsey on Thursday, 23 September 2021 at 10:00 a.m. for the purpose of considering and, if thought fit, passing the following resolutions:Ordinary Business – Ordinary Resolutions1.
THAT the Company’s annual report and audited financial statements for the year ended 31 December 2020 be received and adopted.2.
THAT Ernst & Young LLP be re-appointed as auditor of the Company, to hold such office until the conclusion of the next...
ALSTOM SA : Results of the option to receive the 2020-21 dividend in shares
Written by Customer Service on . Posted in Dividend Reports And Estimates.
Results of the option to receive the 2020/21 dividend in shares
27 August 2021 – The Shareholders’ Meeting of the Company, held on July 28, 2021, offered the option for shareholders to receive the 2020/21 dividend of €0.25 gross per share in cash or in new shares of the Company.
The share price for the new shares to be issued in payment of the 2020/21 dividend was set on July 28, 2021 at 34.21 euros. The terms of dividend payment have been detailed in the press release of 28 July 2021.
The period to exercise the option ran from August 4 to August 25, 2021 included. At the end of the option period, 51,58% of rights were exercised in favour of receiving the payment for the 2020/21 dividend in shares. As a result, 1,401,876 new shares will be issued, representing 0.38% of the Company’s share capital based on the share capital as of July...
Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer
Written by Customer Service on . Posted in Public Companies.
Basel, 27 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the company has made the decision to voluntarily withdraw the US accelerated approval for Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) whose tumours express PD-L1, as determined by a US Food and Drug Administration (FDA)-approved test. Roche made this decision following consultation with the US FDA, based on the agency’s assessment of the current mTNBC treatment landscape and in accordance with the requirements of the accelerated approval programme. This decision only impacts the mTNBC indication in the US. It does not affect other approved indications for Tecentriq in the...
ADLPartner / ADLPerformance: 2021 FIRST-HALF NET SALES: €75.5M (+16.4%)
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASEParis, 27 August 2021 (5:45pm)
ADLPartner / ADLPerformance2021 FIRST-HALF NET SALES: €75.5M (+16.4%)STRONG GROWTH IN DIGITAL MARKETING: €30.9M (+40.7%)
Following robust sales growth during the first quarter of 2021, the ADLPerformance Group ramped up its growth during the second quarter of 2021, with net sales1 of €37.7m, up +29.1% versus the second quarter of 2020 and +12.9% compared with the second quarter of 2019 before the health crisis.
For the first half of 2021, the ADLPerformance Group is reporting consolidated net sales of €75.5m, up +16.4% versus the first half of 2020 and +12.9% versus the first half of 2019. The gross sales volume2 came to €151.2m, up +10.7% compared with the first half of 2020. The Group’s gross margin3 climbed +12.0% to €63.9m.
The Digital Marketing business is capitalizing on the strong commercial...
KBC Ancora closes financial year 2020/2021 with a profit of EUR 529.7 million, including recurring profit of EUR 18.0 million
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Regulated information, Leuven, 27 August 2021 (17.40 hrs CEST)
KBC Ancora closes financial year 2020/2021 with a profit of EUR 529.7 million, including recurring profit of EUR 18.0 million.
KBC Ancora recorded a profit of EUR 529.7 million in the financial year 2020/2021, equivalent to EUR 6.76 per share. This compares with a profit of EUR 60.8 million in the previous financial year. The result was due in very large part to the reversal of the remaining impairments on the participating interest in KBC Group (EUR 511.7 million). The recurring result for the financial year 2020/2021 (EUR 18.0 million) was determined on the one hand by the income from the dividend received on the participating interest in KBC Group (EUR 34.1 million), and on the other by the operating costs (EUR 2.4 million) and interest charges (EUR 13.8 million). ...
Proactive news headlines including Flynn Gold, Global Energy Ventures, MMJ Group Holdings and Australian Potash
Written by Customer Service on . Posted in Mergers And Acquisitions.
Sydney, Aug. 28, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Flynn Gold (ASX:FG1) Ltd has intersected visible gold in first assays from diamond drilling at Brilliant Prospect within the Golden Ridge Project in northeast Tasmania. Click here
Global Energy Ventures Ltd (ASX:GEV) recently signed a Memorandum of Understanding (MoU) with Province Resources Ltd and Total Eren to support a technical and commercial feasibility study on the export of green hydrogen from the HyEnergy Project. Click here
MMJ Group Holdings Ltd (ASX:MMJ, OTC:MMJJF) has completed a US$1 million investment in Brainworks Foundry Inc, an integrated digital health and pathology company operating in the United States. Click here
Paradigm Biopharmaceuticals...
